Single-Arm Phase II Survival Trial Design

En savoir plus sur le livre

Focusing on advanced cancer drug development, this book offers an in-depth overview of single-arm phase II trial designs, particularly those utilizing time-to-event endpoints. It explores various methodologies commonly employed in these trials, highlighting their significance in targeting therapy and immunotherapy. The comprehensive summary serves as a valuable resource for researchers and practitioners aiming to enhance their understanding and application of these trial designs in clinical settings.